Benign neoplasm: Vulva

CD2_BENIGN_VAGINA

vulvar carcinoma: A carcinoma that arises from epithelial cells of the mammalian vulva

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D28.0& Hospital discharge: ICD-8 — 2212 Cause of death: ICD-10 — D28.0& Cause of death: ICD-8 — 2212 2 out of 7 registries used, show all original rules.	754
4. Check minimum number of events None	754
5. Include endpoints None	754
6. Filter based on genotype QC (FinnGen only)	754

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D28
Name in latin: Neoplasma benignum vulvae

NAME	CD2_BENIGN_VAGINA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D280
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	2212
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D280
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	2212
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Vulva based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Vulva

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	5127	5127	-
Only index persons	4729	4729	-
Unadjusted period prevalence (%)
Whole population	0.15	0.15	-
Only index persons	0.17	0.17	-
Median age at first event (years)
Whole population	-	42.27	-
Only index persons	-	41.49	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	754	754	-
Unadjusted period prevalence (%)	0.26	0.26	-
Median age at first event (years)	41.68	41.68	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
678: Matched controls
6780

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D28.0

ICD-10 Finland

Benign neoplasm: Vulva

+∞

323.0

457

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

82.1

160.0

177

22120

ICD-8 Finland

Benign neoplasm of other female genital organs, Vulva

+∞

131.6

122

22121

ICD-8 Finland

+∞

51.7

22122

ICD-8 Finland

+∞

50.7

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

27.9

31.0

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

6.2

25.2

123

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.6

12.7

101

434

8473

FHL

Guinea pig or gland excision

25.5

11.2

N75.0

ICD-10 Finland

Cyst of Bartholin gland

8.5

9.6

J01DA01

ATC

[U] cefalexin; systemic

1.7

9.1

438

3546

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.1

8.5

102

533

R01AD09

ATC

mometasone; nasal

1.6

8.0

325

2483

N90.7

ICD-10 Finland

Vulvar cyst

15.2

7.7

LFW96

NOMESCO Finland

Other operation on vulva or perineum

80.9

7.4

A02BC05

ATC

esomeprazole; systemic

1.6

7.1

289

2188

ULA02

NOMESCO Finland

Kolposcopy

2.0

7.0

489

62212

ICD-8 Finland

Infective diseases of uterus (except cervix), vagina and vulva, Bartholinitis acuta

13.9

6.9

LFC00

NOMESCO Finland

Partial excision of vulva

13.9

6.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

6.9

250

1835

X01

ICPC

Genital pain female

6.9

6.5

R03AC02

ATC

salbutamol; inhalant

1.5

6.4

368

2988

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

137

852

1.74

7.40

5.0

4.4

32.8

34.0

0.65

107

541

(40768804) Tissue Pathology biopsy report

364

2871

1.52

7.26

2.3

2.1

—

(3019225) pH of Specimen

113

699

1.73

6.18

4.6

3.8

—

(3002256) Pathology report gross observation

129

849

1.63

5.56

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

480

4149

1.43

5.20

3.4

2.9

48.6

42.1

u/l

0.58

446

3833

(3013707) Erythrocyte sedimentation rate by Westergren method

557

5020

1.42

4.25

4.4

4.2

12.7

12.6

mm/h

0.10

514

4619

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

360

3039

1.35

4.06

5.2

1.2

mmol/l

0.74

318

2737

(3032080) INR in Blood by Coagulation assay

297

2442

1.36

3.94

8.5

8.1

1.2

inr

0.47

715

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

565

5137

1.40

3.84

7.2

7.1

78.7

77.1

u/l

0.35

529

4798

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

214

1.92

3.56

2.2

2.0

2877.3

2548.7

u/l

0.04

(3023103) Potassium [Moles/volume] in Serum or Plasma

705

6730

1.73

3.47

16.1

15.0

3.9

mmol/l

0.03

688

6525

(3029634) Reagin Ab [Titer] in Serum by VDRL

2.69

3.41

1.5

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

385

3345

1.31

3.31

6.7

5.9

1.2

mmol/l

0.32

319

2825

(3019309) Folate [Moles/volume] in Red Blood Cells

160

1221

1.39

3.30

1.7

1273.0

1215.4

nmol/l

0.25

117

887

(3044640) Blood type and Crossmatch panel - Blood

254

2091

1.32

3.20

2.2

2.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

702

6716

1.66

3.13

16.0

14.9

139.7

mmol/l

0.16

687

6528

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

250

2060

1.32

3.12

2.5

2.3

55.0

56.8

u/l

0.33

232

1873

(3017143) Hepatitis C virus Ab [Presence] in Serum

651

1.49

3.05

1.5

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

200

1601

1.34

3.04

2.5

2.0

—

(3022145) Colonoscopy Study observation

105

757

1.45

2.97

1.3

—

(40768797) Stomach Pathology biopsy report

133

1004

1.39

2.92

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

201

1624

1.32

2.85

1.5

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

2.29

2.79

1.5

1.2

—

nmol/l

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

167

1320

1.34

2.74

1.3

15.1

33.2

iu/ml

4.61

433

(4146454)

2.46

2.72

1.8

2.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

6.04

2.70

3.7

1.3

97.0

88.8

ng/l

—

(3017732) Neutrophils [#/volume] in Blood

450

1.54

2.69

3.4

3.1

4.0

e9/l

0.00

348

(3036481) Cortisol [Moles/volume] in Serum or Plasma

618

1.46

2.67

2.1

367.1

372.3

nmol/l

0.08

570

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

317

2745

1.27

2.59

2.1

2.0

103.1

98.2

pmol/l

0.79

145

1279

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

2.45

2.55

7.7

6.2

13.0

12.5

mg/l

0.13

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

681

6516

1.47

2.51

14.5

13.3

18.5

20.5

mg/l

1.01

552

5094

(3007853) Bacteria identified in Skin by Aerobe culture

678

1.42

2.49

1.8

1.6

—

(3013512) EKG study

231

1938

1.28

2.42

3.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

411

3689

1.25

2.41

3.9

4.2

6.8

6.6

mmol/l

0.95

382

3416

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

388

3461

1.25

2.40

5.1

5.5

10.6

10.3

umol/l

0.15

363

3266

(3052851) Hemolysis interference index of Serum or Plasma

199

1.74

2.36

2.9

3.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

652

6206

1.37

2.33

12.7

12.3

80.1

ml/min/173m2

0.01

548

5044

(3026493) Urate [Moles/volume] in Serum or Plasma

192

1581

1.29

2.32

2.4

9626.0

4557.3

umol/l

0.55

168

1353

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.24

2.31

1.0

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

681

1.40

2.28

2.0

2.2

7.0

6.6

umol/l

0.07

574

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

159

1281

1.31

2.27

1.3

6.5

10.9

u/ml

0.58

470

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

714

6927

1.58

2.13

11.2

10.3

23.3

23.5

u/l

0.13

687

6667

(3021879) Hepatitis B virus core Ab [Presence] in Serum

425

1.47

2.10

1.7

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

345

3070

1.23

2.08

2.4

2.3

80.4

79.8

nmol/l

0.15

291

2741

(3022313) Gas panel - Capillary blood

246

1.62

2.08

2.1

3.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

353

3150

1.23

2.07

3.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

2.05

2.07

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

234

2002

1.24

2.03

1.8

2.1

118.9

146.3

u/l

1.34

216

1886

(42870588) Differential panel, method unspecified - Blood

255

2204

1.24

2.02

7.0

5.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

2.02

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

2.02

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.98

2.01

1.4

1.2

0.6

nmol/l

0.13

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

567

1.40

1.98

3.1

3.2

109.1

78.9

ng/l

1.30

492

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

2.00

1.96

1.4

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.98

1.91

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.98

1.91

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.98

1.91

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

589

5570

1.26

1.90

5.0

4.5

14.6

14.8

pmol/l

1.72

535

5078

(3009508) Creatinine [Moles/volume] in Urine

225

1931

1.24

1.88

3.3

2.9

6.1

6.4

mmol/l

0.44

182

1617

(3031040) Bacteria [#/volume] in Urine by Automated count

487

4527

1.21

1.78

5.3

4.8

1478.2

2410.4

e6/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

339

1.48

1.78

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

119

956

1.29

1.74

1.3

784.3

588.5

titre

0.27

223

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

210

1.60

1.74

2.5

3.6

24.9

25.1

mmol/l

0.15

200

(3025130) Human papilloma virus identified in Specimen

118

1.80

1.71

1.3

1.7

—

(3013115) Eosinophils [#/volume] in Blood

374

3403

1.20

1.68

6.7

5.8

0.2

e9/l

0.09

324

2979

(3002030) Lymphocytes/100 leukocytes in Blood

349

3156

1.20

1.68

6.8

5.8

27.8

28.7

1.03

327

2914

(3037467) Urinalysis macro (dipstick) panel - Urine

496

4632

1.21

1.67

5.3

4.6

—

(3012516) Albumin [Mass/volume] in Urine

212

1829

1.22

1.67

3.4

3.1

411.3

431.2

mg/l

0.02

117

1019

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

659

6345

1.31

1.66

6.0

5.4

1.8

2.1

mu/l

0.70

609

5818

(3019198) Lymphocytes [#/volume] in Blood

368

3349

1.19

1.64

6.4

5.5

1.9

e9/l

0.28

321

2941

(40768446) Kidney Pathology biopsy report

3.59

1.62

1.0

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

731

1.31

1.61

20.1

22.5

1.2

inr

0.05

(3015183) Erythrocyte sedimentation rate

2.71

1.58

1.0

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

707

6888

1.42

1.56

16.1

15.4

71.4

69.5

umol/l

0.71

707

6888

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.05

1.55

1.6

1.5

—

(3006315) Basophils [#/volume] in Blood

360

3282

1.19

1.54

6.7

5.5

0.0

e9/l

0.10

312

2818

(3018010) Neutrophils/100 leukocytes in Blood

344

3124

1.19

1.54

6.6

5.5

58.2

56.8

1.45

321

2897

(3020682) Albumin/Creatinine [Ratio] in Urine

220

1923

1.20

1.50

4.0

3.7

15.9

6.9

mg/mmol

1.02

126

1071

(40761511) CBC panel - Blood by Automated count

697

6780

1.37

1.50

14.2

12.5

—

(3022096) Basophils/100 leukocytes in Blood

328

2972

1.18

1.50

6.8

5.7

0.7

1.13

307

2736

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.96

1.49

1.6

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

266

2371

1.19

1.46

3.3

3.4

24.7

43.1

ng/l

0.60

156

1582

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.14

1.44

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.81

1.44

1.4

1.8

—

(3001604) Monocytes [#/volume] in Blood

357

3268

1.18

1.42

6.4

5.5

0.6

0.5

e9/l

0.28

307

2807

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

641

6176

1.25

1.42

4.1

3.9

1.3

1.2

mmol/l

0.61

584

5601

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

628

6041

1.24

1.39

5.9

5.6

40.1

39.3

mmol/mol

1.34

575

5567

(3003888) Timothy IgE Ab [Units/volume] in Serum

1.82

1.38

1.1

10.8

1.9

u/ml

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

113

1.70

1.33

1.3

1.2

—

(3019069) Monocytes/100 leukocytes in Blood

337

3087

1.17

1.30

7.1

5.9

8.4

8.3

0.22

316

2859

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

204

1794

1.19

1.29

2.4

2.8

1129.5

982.5

ng/l

0.19

165

1500

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.37

1.29

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.37

1.29

2.3

1.5

—

(3007461) Platelets [#/volume] in Blood

731

7188

1.56

1.29

22.2

20.0

263.5

261.9

e9/l

0.28

714

7011

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1.80

1.28

1.1

1.3

0.7

u/ml

—

(3024731) MCV [Entitic volume]

731

7189

1.55

1.27

22.1

19.9

91.0

0.05

725

7082

(3006504) Eosinophils/100 leukocytes in Blood

335

3072

1.16

1.26

6.7

5.6

2.8

2.7

0.25

312

2828

(3026361) Erythrocytes [#/volume] in Blood

731

7190

1.55

1.26

22.2

20.0

4.4

e12/l

0.19

714

6992

(3035941) MCH [Entitic mass]

731

7190

1.55

1.26

22.1

19.9

30.1

30.2

0.30

725

7082

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

184

1608

1.19

1.25

2.3

2.2

2.9

3.1

mg/l

0.26

160

1350

(3000963) Hemoglobin [Mass/volume] in Blood

731

7191

1.54

1.24

22.3

20.1

131.7

g/l

0.01

725

7085

(3010813) Leukocytes [#/volume] in Blood

731

7191

1.54

1.24

22.2

20.0

6.6

6.5

e9/l

0.51

711

6990

(4211845)

2.23

1.24

2.6

3.3

—

(3045414) Leukocytes [Presence] in Urine

314

1.39

1.23

1.4

2.0

—

(3026008) Bacteria identified in Urine by Culture

262

2363

1.17

1.22

3.4

3.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

309

2824

1.16

1.21

4.9

4.1

35.6

35.8

g/l

0.24

284

2607

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

109

909

1.23

1.20

1.6

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.32

1.19

1.5

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.32

1.19

1.5

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

662

6428

1.24

1.18

4.6

4.4

1.6

mmol/l

0.52

607

5891

(3000492) Spirometry study

556

1.29

1.16

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.06

1.15

3.0

6.5

—

(3037121) Protein [Mass/volume] in Urine

208

1.46

1.14

2.4

3.0

0.4

0.3

g/l

0.33

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

182

1604

1.18

1.12

1.3

0.5

1.5

u/ml

3.47

396

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.35

1.12

1.7

2.1

33.9

50.5

ug/l

—

(3014271) Vancomycin [Susceptibility]

2.35

1.12

2.6

2.5

—

(21494434) Karyotype in Bone marrow

1.97

1.11

1.1

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

329

1.36

1.11

2.9

3.3

1.3

2.1

mmol/l

0.75

259

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

523

0.73

1.11

2.6

2.5

46.6

67.6

ml/min/173m2

2.33

214

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.68

1.11

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

144

1.54

1.09

1.6

1.7

4759.3

16663.1

e6/l

1.46

102

(40768443) Skin Pathology biopsy report

304

1.37

1.09

1.1

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

665

6470

1.24

1.09

4.6

4.4

4.8

mmol/l

1.53

612

5962

(1761482) Bacteria [#/volume] in Urine by Culture

163

0.55

1.09

6.1

4.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

762

1.24

1.09

6.4

4.1

1.1

1.0

mmol/l

0.45

693

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.70

1.08

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.88

1.07

1.4

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

375

1.33

1.07

1.4

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

428

4027

1.15

1.07

3.2

3.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

411

3857

1.14

1.07

8.2

8.8

4.2

3.9

e9/l

1.19

360

3374

(3048689) Calprotectin [Mass/mass] in Stool

104

875

1.22

1.07

2.1

2.0

85.1

121.9

ug/g

1.11

670

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

233

2103

1.16

1.06

2.8

26.6

29.3

u/l

1.49

220

2002

(3011985) Renin [Units/volume] in Plasma

1.72

1.05

2.0

1.4

26.0

42.3

mu/l

0.47

(4010399)

483

1.29

1.05

1.2

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

457

1.29

1.04

1.4

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1.65

1.04

1.4

1.3

—

(3017704) Immunofixation for Urine

2.07

1.03

4.3

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.90

1.01

2.2

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

321

2971

1.14

1.01

3.2

2.8

81.5

90.4

ug/l

0.81

293

2726

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.82

0.99

2.9

2.6

—

(36660697) Celiac disease serology panel - Serum

580

1.25

0.97

1.2

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.66

0.95

1.6

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.74

0.92

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

151

1.47

0.91

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

219

1.39

0.90

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

169

0.59

0.89

1.9

1.7

—

(3036603) Volume of Urine

1.87

0.87

1.1

1.4

—

2351.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.01

0.87

1.5

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.01

0.87

1.5

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

239

1.35

0.85

1.9

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1.68

0.85

1.6

1.4

—

(3045424) Erythrocytes [Presence] in Urine

112

1.53

0.85

1.1

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

645

1.22

0.85

3.5

2.6

1.9

0.06

562

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

674

6595

1.21

0.85

5.2

5.0

2.8

mmol/l

1.12

622

6050

(3006462) Nitrate [Presence] in Urine

1.94

0.84

3.0

3.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

591

1.22

0.84

2.3

2.0

0.2

g/l

0.34

567

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1.75

0.82

1.4

1.2

1.1

1.7

nmol/l

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

260

0.68

0.82

2.3

2.2

3.8

3.7

g/l

0.20

195

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

260

0.68

0.82

2.3

2.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

105

1.54

0.82

1.0

—

14.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

109

947

1.18

0.82

2.8

2.2

12.7

umol/l

0.02

104

866

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1.56

0.82

1.3

1.1

5.3

2.0

u/ml

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.73

0.80

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.73

0.80

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.73

0.80

1.3

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.79

0.0

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

0.79

0.0

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.67

0.79

2.5

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.67

0.79

2.5

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.67

0.79

2.5

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

287

1.30

0.78

1.4

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

157

1409

1.14

0.78

1.6

1.7

64341544.3

15157244.4

pmol/l

0.35

129

1148

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

368

1.27

0.78

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

1.77

0.76

1.0

1.1

48.3

68.9

u/l

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.76

0.0

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

218

1.34

0.76

1.8

1.9

6.9

2.3

ug/l

0.50

193

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.70

0.76

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.70

0.76

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.70

0.76

1.3

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

527

5450

0.89

0.75

18.1

16.4

13.8

13.7

1.00

515

5330

(3004588) Protein electrophoresis panel - Serum or Plasma

457

0.78

0.75

2.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

657

6430

1.17

0.73

4.7

4.5

5.9

5.8

mmol/l

0.53

600

5823

(3007164) IgA [Mass/volume] in Serum or Plasma

151

1360

1.14

0.71

1.4

1.5

2.2

g/l

0.10

771

(44790049)

1.59

0.71

2.2

1.5

—

(44790048)

1.59

0.71

2.2

1.5

—

(44806118)

1.59

0.71

2.2

1.5

—

(44790047)

1.59

0.71

2.2

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.93

0.70

1.2

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

101

1.49

0.70

1.1

1.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

866

1.16

0.70

2.7

2.2

2.4

g/l

0.18

800

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.56

0.70

2.1

2.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

118

1048

1.15

0.69

1.8

1.7

—

(3047189) Immunofixation for 24 hour Urine

1.86

0.68

2.0

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

127

1.43

0.68

3.2

2.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.63

0.67

1.6

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1.55

0.66

2.8

1.6

38.5

56.7

u/ml

0.12

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.62

0.65

2.2

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.73

0.64

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.73

0.64

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.73

0.64

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

164

1.35

0.63

1.4

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

113

1008

1.14

0.63

3.3

2.7

0.8

mmol/l

0.49

937

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

173

1.34

0.62

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

167

1528

1.12

0.62

1.8

1.7

0.9

1.0

mg/l

0.10

124

1147

(4024509)

1.60

0.62

1.3

1.6

—

(3024263) Appearance of Synovial fluid

1.67

0.61

4.0

1.6

—

(3019150) Specific gravity of Urine by Refractometry

131

1447

0.89

0.61

4.2

4.3

1.0

kg/l

0.34

218

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

0.60

0.0

1.4

—

(3017569) Oxygen content in Arterial blood

0.00

0.60

0.0

2.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

105

1.44

0.60

2.3

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

174

1600

1.11

0.59

3.7

3.3

96.7

95.2

0.36

168

1551

(3033799) Differential panel - Peritoneal fluid

0.00

0.59

0.0

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

242

0.74

0.58

2.3

3.1

g/l

0.05

198

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.58

0.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.58

0.0

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

167

1.33

0.57

1.7

2.3

—

(3020891) Body temperature

221

1.28

0.56

3.7

4.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

126

0.63

0.54

5.5

2.8

8.7

8.0

kpa

—

119

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.58

0.54

1.5

1.8

8.1

9.6

ug/l

—

(3051651) Icteric interference index of Serum or Plasma

1.58

0.54

3.2

2.8

—

(3004616) Nuclear Ab [Presence] in Serum

1.42

0.54

1.4

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

470

1.18

0.54

3.9

2.7

74.6

73.3

e9/l

0.10

352

(3000494) Fungus identified in Specimen by Culture

781

1.14

0.54

1.7

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.49

0.53

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

257

2424

1.09

0.53

3.3

2.4

mmol/l

0.13

205

2105

(3023511) Choriogonadotropin [Units/volume] in Urine

135

0.66

0.52

1.2

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

804

1.14

0.51

2.5

2.3

20.9

21.5

0.17

680

(3044927) Protein electrophoresis panel - Urine

1.47

0.51

1.4

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.47

0.50

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.47

0.50

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

136

1.33

0.49

2.2

1.5

—

(4306422)

1.44

0.49

1.2

1.1

—

(4035726)

616

1.15

0.49

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

683

1.14

0.49

3.7

3.8

3.0

10.3

ug/l

3.52

549

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

155

0.71

0.48

1.0

1.2

3.8

mmol/l

0.09

145

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

172

1.29

0.48

1.0

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

337

1.20

0.47

1.1

—

105.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

758

0.87

0.47

1.9

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

567

0.85

0.46

3.1

3.5

1.2

mmol/l

0.57

486

(3022621) pH of Urine by Test strip

459

1.17

0.46

2.7

3.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

142

0.70

0.46

1.3

1.6

—

(3044941) Cell count panel - Synovial fluid

103

1.37

0.45

1.2

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

498

1.16

0.45

1.4

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.38

0.44

1.1

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.37

0.44

1.0

—

(3000991) Gas panel - Venous blood

443

1.16

0.44

6.1

6.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

131

1210

1.10

0.43

1.6

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.62

0.43

1.4

14.9

14.5

pmol/l

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.62

0.43

1.8

3.5

862.0

1047.7

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.57

0.42

1.2

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

587

1.14

0.42

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.36

0.41

1.5

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.41

0.0

1.9

—

6.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

141

1.28

0.40

2.2

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

353

1.17

0.40

1.5

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

391

1.16

0.39

1.9

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

105

0.66

0.39

1.1

1.2

—

(44806420)

0.00

0.39

0.0

2.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

553

1.13

0.38

1.2

174.2

165.4

iu/ml

0.07

226

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

639

1.12

0.38

3.4

4.2

244.6

249.1

u/l

0.10

602

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

243

1.20

0.38

1.3

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.33

0.37

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

1.35

0.37

2.4

2.3

1.4

2.3

ug/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.35

0.37

1.0

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

612

1.12

0.37

2.0

1.5

1.3

1.59

536

(3022806) Fractional oxyhemoglobin in Capillary blood

1.39

0.37

2.7

2.1

93.3

89.8

—

(3023410) Appearance of Cerebral spinal fluid

0.64

0.35

1.4

1.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.63

0.35

1.4

2.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.43

0.35

2.7

1.8

—

(40768806) Pleura Pathology biopsy report

1.40

0.35

1.0

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

127

1186

1.09

0.34

3.7

242.1

365.1

ng/l

0.25

883

(21494755) Public health laboratory ask at order entry panel

502

1.12

0.33

1.4

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

196

1864

1.07

0.33

2.9

3.1

90.7

54.9

e6/l

0.26

145

1401

(3042631) Mycobacterium sp identified in Specimen

0.69

0.33

2.2

2.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.28

0.32

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

638

1.11

0.32

2.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

110

1.28

0.32

1.4

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

174

1.21

0.31

1.3

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

181

1720

1.07

0.31

2.9

3.0

0.3

0.4

e6/l

0.54

129

1279

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

165

1.22

0.31

2.3

2.7

0.4

u/ml

0.08

103

(3003327) Ova and parasites identified in Stool by Light microscopy

251

0.83

0.31

1.3

1.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

515

1.12

0.30

3.2

3.8

0.0

0.1

2.51

122

(3018095) Leukocytes [#/volume] in Urine

237

2275

1.06

0.30

3.2

3.6

85.2

92.2

e6/l

0.08

153

1536

(3008295) Osmolality of Serum or Plasma

1.34

0.30

2.1

1.4

280.9

274.6

mosm/kgh2o

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.30

0.30

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

612

1.10

0.30

2.1

2.2

33.9

36.5

u/l

0.20

509

(40760892) CBC W Ordered Manual Differential panel - Blood

138

1461

0.93

0.30

4.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

148

1.22

0.29

1.2

—

(3019060) Gas panel - Arterial blood

364

1.13

0.29

3.9

4.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

106

0.75

0.29

1.3

—

(3025159) Blasts/100 leukocytes in Blood

489

1.11

0.28

3.4

3.9

0.0

0.9

0.50

101

(3045142) Bone marrow Pathology biopsy report

1.29

0.28

1.6

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

140

1.22

0.27

1.4

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

243

2519

0.95

0.27

4.2

4.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

840

1.08

0.26

7.3

6.3

—

(3000330) Specific gravity of Urine by Test strip

341

0.87

0.26

2.6

3.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.69

0.26

2.4

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.68

0.26

1.4

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.68

0.26

1.4

2.1

31.2

31.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

203

0.83

0.26

1.5

1.3

157.4

233.8

miu/ml

—

(3038026) Centromere Ab [Units/volume] in Serum

1.25

0.25

1.1

—

88.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

560

1.10

0.25

1.3

1.4

—

(3021788) Differential panel - Synovial fluid

123

1.22

0.25

1.2

1.7

—

(3005570) Glucose [Moles/volume] in Urine

1.24

0.25

1.6

2.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

361

0.88

0.25

1.3

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

683

0.92

0.25

2.0

1.7

—

(3042936) Bacteria identified in Isolate by Culture

882

1.08

0.24

2.0

1.9

—

(40768795) Lymph node Pathology biopsy report

1.17

0.24

1.2

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

190

0.84

0.23

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.28

0.23

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.28

0.23

1.6

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

574

1.09

0.22

2.1

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.25

0.22

1.0

526.2

362.6

ng/l

—

(40761535) Cells panel - Urine sediment

513

0.91

0.22

3.3

3.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

144

1.18

0.22

2.7

2.0

130.0

128.1

g/l

—

107

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.22

0.22

1.0

795.0

680.1

ng/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.22

0.22

1.0

76.8

56.6

ng/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.19

0.21

1.6

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3018418) pH of Serum or Plasma

212

2050

1.05

0.21

3.6

7.4

0.13

379

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(4015189)

0.00

0.21

0.0

4.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.21

0.0

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

103.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

214

2209

0.96

0.20

2.6

2.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.20

0.0

1.1

—

(3034426) Prothrombin time (PT)

0.00

0.20

0.0

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.00

0.20

0.0

1.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

500

1.09

0.20

3.3

3.7

0.7

0.01

(3026782) Osmolality of Urine

129

1234

1.05

0.20

2.7

2.6

464.0

511.0

mosm/kgh2o

1.85

105

1045

(3041096) Erythrocytes [Presence] in Urine by Automated

184

1777

1.05

0.19

3.7

3.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

193

1.14

0.19

1.5

1.6

0.6

0.1

iu/ml

—

(3024928) Oxygen saturation in Venous blood

127

1.18

0.19

5.6

2.2

—

(40768441) Liver Pathology biopsy report

1.18

0.19

1.2

—

(36304419) Bacteria [Presence] in Urine

177

1709

1.05

0.19

2.8

2.9

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

222

1.13

0.19

4.4

5.0

2.0

1.5

0.81

208

(40767503) Oxygen content in Capillary blood by calculation

118

1.19

0.19

4.4

2.3

16.7

15.9

—

(3039000) Anion gap in Blood

118

1.19

0.19

6.3

7.3

10.7

11.0

mmol/l

0.15

106

(3018572) Chloride [Moles/volume] in Blood

118

1.19

0.19

6.4

7.3

104.1

105.4

mmol/l

0.46

106

(3015736) pH of Urine

252

2588

0.96

0.19

3.5

3.6

—

(3006270) Folate [Moles/volume] in Blood

1.16

0.19

1.3

1.2

506.0

372.8

nmol/l

—

(3009261) Glucose [Presence] in Urine by Test strip

342

3350

1.04

0.19

3.8

3.9

0.0

estimate

0.80

594

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

121

0.82

0.18

1.9

1.6

—

(4094501)

174

0.86

0.18

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.15

0.17

2.9

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

278

0.90

0.17

5.9

8.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.74

0.17

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

152

0.85

0.17

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.16

0.16

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.14

0.16

1.3

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

139

1.15

0.16

3.2

3.7

25.7

18.6

mg/l

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

183

0.87

0.16

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1.13

0.16

1.1

—

61.9

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

1.13

0.16

1.1

—

43.4

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.13

0.16

3.0

2.6

12.8

13.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

151

0.86

0.16

1.5

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

513

0.93

0.15

2.8

65.3

67.1

g/l

0.62

467

(3023420) DNA double strand Ab [Units/volume] in Serum

1.21

0.15

1.0

1.5

—

22.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.16

0.15

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

182

0.88

0.15

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

188

1.12

0.15

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

244

0.90

0.15

1.0

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

181

0.88

0.14

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

181

0.88

0.14

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

338

3324

1.03

0.14

5.2

5.3

0.0

estimate

0.50

603

(1002224) Polysomnography panel

233

0.90

0.14

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

191

0.89

0.14

2.1

2.0

—

(3005033) Fetal Nuchal fold Thickness US

149

0.87

0.13

1.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

100

0.80

0.13

1.3

1.4

—

(3021901) Oxygen saturation in Capillary blood

100

0.80

0.13

4.6

2.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

953

1.04

0.13

2.5

2.7

4.4

4.3

e6/l

0.04

473

(1616796) Gas panel - Central venous blood

113

1.15

0.13

7.1

3.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

209

1.10

0.13

2.7

1.8

9.0

4.8

iu/l

—

(3029937) Albumin [Presence] in Urine by Test strip

181

1766

1.03

0.12

4.0

4.2

0.0

estimate

1.08

598

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1.18

0.12

2.6

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

241

0.91

0.12

1.0

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

168

0.89

0.11

1.0

1.3

439.1

487.3

mg/l

0.42

158

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

353

0.93

0.11

1.6

1.5

—

(3025941) Bacteria identified in Stool by Culture

404

0.94

0.11

1.1

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

544

1.05

0.11

3.2

3.8

0.4

1.0

1.34

136

(40768793) Breast Pathology biopsy report

270

0.92

0.10

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

484

0.95

0.10

2.0

2.3

4.4

6.1

ug/l

0.85

416

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.15

0.10

1.3

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

687

0.96

0.10

2.0

1.7

—

(3012441) Differential panel - Pleural fluid

1.14

0.10

1.6

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.14

0.10

1.6

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

320

1.07

0.10

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.11

0.10

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.06

0.09

1.8

1.3

1.2

1.0

g/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.06

0.09

1.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

116

1.12

0.09

2.2

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

360

0.94

0.09

2.8

2.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

155

1.10

0.09

2.2

2.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.14

0.09

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

532

0.96

0.08

1.5

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

100

973

1.03

0.08

2.1

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

481

0.95

0.08

5.7

3.0

4.4

4.5

pmol/l

0.42

420

(3011288) Drugs identified in Urine by Screen method

107

1.12

0.08

8.2

1.7

—

(3021589) Normoblasts [#/volume] in Blood

294

2904

1.02

0.08

9.4

9.0

0.0

e9/l

2.96

240

2369

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.03

0.08

1.0

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.82

0.08

1.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.79

0.08

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.09

0.08

3.0

3.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.84

0.07

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

0.82

0.07

1.8

2.8

—

(3016018) Differential panel - Cerebral spinal fluid

1.08

0.07

1.1

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

306

0.95

0.07

1.4

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

135

1325

1.02

0.07

2.5

5.7

8.1

e6/l

1.57

115

1170

(1001926) Buprenorphine [Presence] in Urine by Screen method

128

1.10

0.06

3.4

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.11

0.06

1.2

1.3

—

(4281824)

105

0.86

0.06

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

158

1.08

0.06

2.4

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

385

0.96

0.06

1.4

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

202

0.94

0.05

1.5

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

130

1.08

0.04

3.4

3.3

4.6

4.4

e9/l

0.12

130

(3003694) ABO and Rh group [Type] in Blood

172

1740

0.99

0.04

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

140

0.93

0.04

4.3

4.6

—

(3027008) Opiates [Presence] in Urine

160

1.06

0.04

2.9

1.4

—

(3028300) Cannabinoids [Presence] in Urine

160

1.06

0.04

2.9

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

160

1.06

0.04

2.9

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

590

5882

1.01

0.04

16.0

14.6

39.0

38.8

0.13

438

4140

(40758558) Short blood count panel - Blood

175

1733

1.01

0.03

6.2

6.6

—

(3037756) Immunofixation for Serum or Plasma

139

0.93

0.03

3.3

1.8

—

(3012544) pH of Venous blood

538

1.02

0.03

6.5

2.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

181

1.05

0.03

2.0

1.8

96.4

0.00

171

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

184

1825

1.01

0.03

1.6

1.3

mmol/l

0.55

164

1530

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

211

1.04

0.03

1.3

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

219

0.96

0.03

1.2

1.4

324.6

300.8

ug/g

—

126

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

239

0.96

0.02

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

269

0.97

0.02

2.0

1.6

—

(3049717) Cytology report of Urine Cyto stain

172

1.05

0.02

2.6

2.4

—

(3002032) Base excess in Venous blood by calculation

521

1.02

0.02

6.7

2.8

2.3

2.1

mmol/l

0.11

421

(3008898) HLA-B27 [Presence]

258

0.97

0.02

1.0

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

102

1030

0.99

0.02

2.4

2.6

1.7

1.3

e6/l

0.32

551

(3044889) 12 lead EKG panel

459

4579

1.01

0.01

3.8

3.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

156

1551

1.01

0.01

1.6

1.5

23.0

22.2

nmol/l

0.23

122

1300

(3003396) Base excess in Arterial blood by calculation

643

1.01

0.01

4.6

6.3

1.7

1.3

mmol/l

0.37

517

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

126

0.95

0.00

1.6

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

126

0.95

0.00

1.6

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

136

0.96

0.00

1.1

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

664

1.01

0.00

3.5

3.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

1.05

0.00

6.9

1.7

56.1

60.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

105

1.05

0.00

2.0

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

135

1.04

0.00

3.4

3.5

61.4

59.1

0.32

135

(3024891) Influenza virus A+B Ag [Presence] in Specimen

164

0.98

0.00

1.1

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

285

0.98

0.00

2.5

2.1

37.4

39.7

u/l

0.24

249

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

167

1.02

0.00

1.3

1.4

—

(4034850)

193

0.98

0.00

16.7

8.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

207

1.01

0.00

1.5

1.6

—

148.0

—

(3016879) Cocaine [Presence] in Urine

148

1.01

0.00

3.2

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

222

0.99

0.00

4.8

5.0

1.0

0.9

0.90

208

(3035350) Ketones [Presence] in Urine by Test strip

328

3284

1.00

0.00

3.8

3.9

0.0

estimate

0.00

601

(40761536) Microorganisms panel - Urine sediment

568

1.00

0.00

3.8

4.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

639

1.00

0.00

4.8

6.4

12.2

12.5

kpa

0.20

614

(3023368) Bacteria identified in Blood by Culture

152

1521

1.00

0.00

4.2

3.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

156

1561

1.00

0.00

3.5

3.9

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.0

2.6

—

59.9

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.8

—

(4212803)

0.00

0.0

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.0

1.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.3

—

(3001729) Color of Synovial fluid

0.00

0.0

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

10.4

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.4

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.7

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

132

1320

1.00

0.00

3.1

2.7

2.5

mmol/l

0.06

111

1165

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

0.95

0.00

3.6

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.85

0.00

2.6

2.5

—

(3051611) Lipemic interference index of Serum or Plasma

1.01

0.00

3.4

2.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.0

1.3

—

(44813793)

0.89

0.00

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.93

0.00

2.4

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

0.96

0.00

4.6

4.9

360.1

374.1

umol/l

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.96

0.00

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.96

0.00

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.0

1.4

—

(3042733) HLA Ab [Presence] in Serum

0.00

0.0

2.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.00

0.00

2.1

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

1.02

0.00

1.3

1.2

32.4

33.5

g/l

—

(3024932) HLA-DR beta [Type]

0.00

0.0

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.4

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.3

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

0.0

1.0

—

6.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.0

5.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.0

1.9

—

16.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.94

0.00

1.2

1.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.91

0.00

1.5

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

350

1.00

0.00

4.3

2.5

121.6

127.0

g/l

0.77

342

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.98

0.00

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.0

1.8

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.96

0.00

1.2

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.00

0.00

1.2

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_VAGINA and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_VAGINA	0.981 [0.85, 1.14]	0.799
Birth year	0.997 [0.99, 1.01]	0.46

During the follow-up period (1.1.1998 — 31.12.2019), 326 out of 2726 females with CD2_BENIGN_VAGINA died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_VAGINA.

N-year risk	Females	Males
1	0.083%	No data
5	0.496%	No data
10	1.422%	No data
15	2.908%	No data
20	5.287%	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_VAGINA – Benign neoplasm: Vulva

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Vulva

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints